Cerus Endovascular Ltd — Form D/A
Cerus Endovascular Ltd of OXFORD, X0, a company, filed a Form D amendment with the SEC on 2019-08-26. The offering totals $20.0M, of which $5.9M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2019-08-26
- Form: D/A
- Accession: 0000945621-19-000288
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $20.0M
- Amount sold: $5.9M
- Remaining: $14.1M
- Minimum investment: $100K
- Investors: 49
- Date of first sale: 2018-01-04
- Security types: equity, debt
- Revenue range: Decline to Disclose
- SEC file number: 021-303440
Issuer
- Name: Cerus Endovascular Ltd
- CIK: 0001676056
- Entity type: Other
- Jurisdiction: UNITED KINGDOM
- Address: JOHN ECCLES HOUSE, OXFORD, X0, OX44G8
- Phone: 44(0)1865578597
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Franklin Berger | Director | Newark, CA |
| Paul A Brooke | Director | Oxford, X0 |
| Stephen J Griffin | Director | Oxford, X0 |
| John J Kilcoyne | Director | Oxford, X0 |
| Sam J Milstein | Director | Oxford, X0 |
| David Jennings | Executive Officer | Oxford, X0 |
| J Todd Derbin | Director | Oxford, X0 |
Other filings by this issuer (3)
More